Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Publications are described as automatically filled from PubMed, and a Revision: v3.3.2 note was added. These edits are editorial and do not affect the study content or participation details.
    Difference
    0.1%
    Check dated 2025-11-27T04:28:17.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The bottom notice about government funding/operating status was removed. The page no longer displays information about potential delays or where to check operating status.
    Difference
    0.2%
    Check dated 2025-11-19T22:14:40.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    The Locations section now lists updated study sites across multiple countries, with some sites added and others removed. This changes where the trial is recruiting and how to reach the appropriate site for enrollment.
    Difference
    0.2%
    Check dated 2025-10-29T10:10:07.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    Update includes a new operating status notice and version bump to v3.2.0; removal of the previous v3.1.0 note indicates version update.
    Difference
    1%
    Check dated 2025-10-07T23:22:53.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Updated page version from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-30T02:46:36.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Core content on drug safety and related topics has been removed, reducing important information about drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs.
    Difference
    0.1%
    Check dated 2025-09-22T23:38:11.000Z thumbnail image

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.